Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has
As filed · Outcome of Board Meeting
CapitalImprovingMinormateriality 46 out of 100
What happened
FactBoard of Directors of Alembic Pharmaceuticals Limited at its meeting held today has. Recommended a dividend of Rs. 11/- (550%) per Equity Share having face value. of Rs. 2/- each, subject to approval of the Shareholders at the ensuing Annual.
Why it matters
CapitSignal interpretationA dividend moves cash off the balance sheet to shareholders, so it is both a return and a statement about how much cash the business does not need.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Debt
WithdrawnEarlierQ1 FY27
gross debt was about -- we are at around INR1,600 crores of gross debt.
NowQ1 FY27
we should see this debt levels moderating.
Change
FactGuidance withdrawn
Implication
CapitSignal interpretationDetected a change between two statements on this topic.confidence 60%
Watch next
Fact- Record date
- Payout as a share of profit
- I think about 15-odd percent or so of what I've guided for that the business will grow, and I think we're quit (management committed by FY27)
- Expenditures on artificial intelligence within the healthcare sector are anticipated to attain a value of US$ (management committed by FY30)
Evidence
- Alembic Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 06, 2025.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- DIVIDEND base 38; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%